# EDGAR Filing Document

**Accession Number:** 0001962070
**File Stem:** 0001562180-23-000537
**Filing Date:** 2023-1
**Character Count:** 5157
**Document Hash:** e6643681ff9bf6ba538c14beec5ef2d9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001562180-23-000537.hdr.sgml**: 20230120

**ACCESSION NUMBER**: 0001562180-23-000537

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230110

**FILED AS OF DATE**: 20230120

**DATE AS OF CHANGE**: 20230120

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** McGann Michael J.
- **CENTRAL INDEX KEY:** 0001962070

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35229
- **FILM NUMBER:** 23541720

**MAIL ADDRESS:**
- **STREET 1:** 301 WATER STREET
- **STREET 2:** SUITE 200
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20003
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Xylem Inc.
- **CENTRAL INDEX KEY:** 0001524472
- **STANDARD INDUSTRIAL CLASSIFICATION:** PUMPS & PUMPING EQUIPMENT [3561]
- **IRS NUMBER:** 452080495
- **STATE OF INCORPORATION:** IN
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 301 WATER STREET SE
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20003
- **BUSINESS PHONE:** 202-869-9150

**MAIL ADDRESS:**
- **STREET 1:** 301 WATER STREET SE
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20003

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ITT WCO, Inc.
- **DATE OF NAME CHANGE:** 20110628

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>McGann Michael J.<br><sub>(Last) (First) (Middle)</sub><br>C/O XYLEM, INC.<br>301 WATER STREET SE, SUITE 200<br><sub>(Street)</sub><br>WASHINGTON, DC 20003<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Xylem Inc. [ XYL ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2023-01-10 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Senior Vice President_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 1365.00<sup>(1)</sup> | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Stock Option (Right to buy) | <sup>(2)</sup> | 2030-02-27 | Common Stock | 1193.00 | $80.66 | D |  |
| Stock Option (Right to buy) | <sup>(3)</sup> | 2031-03-01 | Common Stock | 2694.00 | $102.23 | D |  |
| Stock Option (Right to buy) | <sup>(4)</sup> | 2032-03-01 | Common Stock | 3147.00 | $86.76 | D |  |

---

### Footnotes:

(1) Reflects restricted stock units which are scheduled to vest as follows: 236 on February 27, 2023, 202 on March 1, 2023, 207 on March 1, 2024, 238 on March 1, 2023, 238 on March 1, 2024 and 244 on March 1, 2025. Each restricted stock unit represents the right to receive one share of common stock upon vesting.

(2) 1,193 options are scheduled to vest on February 27, 2023.

(3) 890 options are fully vested and exercisable, 889 are scheduled to vest on March 1, 2023 and 915 are scheduled to vest on March 1, 2024.

(4) These options are scheduled to vest in one-third increments on March 1, 2023, March 1, 2024 and March 1, 2025.

**Signature:** /s/ Callie Plant, by power of attorney for Michael J. McGann  
**Date:** 2023-01-20

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**